These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21922151)

  • 1. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma.
    Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G
    Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
    Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
    J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion.
    Lenz J; Karasek P; Jarkovsky J; Muckova K; Dite P; Kala Z; Veselska R; Hermanova M
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):389-96. PubMed ID: 22187705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma.
    Welsch T; Keleg S; Bergmann F; Bauer S; Hinz U; Schmidt J
    Pancreas; 2009 Nov; 38(8):968-76. PubMed ID: 19672209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
    Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
    Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
    Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma.
    An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS
    Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells.
    Zhu Y; Karakhanova S; Huang X; Deng SP; Werner J; Bazhin AV
    Exp Cell Res; 2014 Jun; 324(2):146-56. PubMed ID: 24726912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
    Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L
    Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
    Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
    Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin and other putative cancer stem cell markers in pancreatic cancer.
    Matsuda Y; Kure S; Ishiwata T
    Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of c-kit expression in pancreatic adenocarcinoma: a novel stem cell marker responsible for the progression of the disease.
    Amsterdam A; Raanan C; Polin N; Melzer E; Givol D; Schreiber L
    Acta Histochem; 2014 Jan; 116(1):197-203. PubMed ID: 23978330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Wen Z; Liao Q; Zhao J; Hu Y; You L; Lu Z; Jia C; Wei Y; Zhao Y
    Ann Surg Oncol; 2014 Jan; 21(1):125-32. PubMed ID: 24132627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
    Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H
    Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
    Tsukahara M; Nagai H; Kamiakito T; Kawata H; Takayashiki N; Saito K; Tanaka A
    Pathol Int; 2005 Feb; 55(2):63-9. PubMed ID: 15693851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expressions of p53 and Gadd45a proteins in human pancreatic cancer and their clinicopathological significance].
    Dong M; Zhou JP; Kong FM; Guo KJ; Tian YL; Dong YT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):628-32. PubMed ID: 16274047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients.
    Sanlioglu AD; Dirice E; Elpek O; Korcum AF; Ozdogan M; Suleymanlar I; Balci MK; Griffith TS; Sanlioglu S
    Pancreas; 2009 Mar; 38(2):154-60. PubMed ID: 18981952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.